News | September 24, 2025
Briefs: Relonchem, Patel Chem Specialities and J & H Pharma Consultants
Relonchem receives marketing authorization for Moxonidine tablets
Relonchem receives marketing authorization for Moxonidine tablets
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
Alkem Medtech to acquire 100% stake of Bombay Ortho
USFDA inspection at Emcure Pharmaceuticals API facility
Relonchem Limited has received Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets from UK MHRA
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (Middle East & North Africa) region
The product will be marketed under store brand labels and is comparable to the brand Zyrtec
Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
